ADC Therapeutics To Wind Up Zynlonta Study In Frail Patients After Deaths

Study To End Despite No Clear Link With Treatment

 
• By Andrew McConaghie
Frail Patient
The study aimed to help elderly patients who were frail and unfit for standard first line chemotherapy treatment.

More from Business

More from Scrip